⌘K

Home/Filings/4/0001209191-19-004861

4//SEC Filing

MORNEAU MICHAEL 4

Accession 0001209191-19-004861

CIK 0001607678other

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 7:13 PM ET

Size

4.8 KB

Accession

0001209191-19-004861

Insider Transaction Report

Form 4

Period: 2019-01-19

Viking Therapeutics, Inc.VKTX

MORNEAU MICHAEL

Chief Financial Officer

Transactions

Tax Payment
Common Stock, par value $0.00001 per share
2019-01-19$8.78/sh−2,044$17,946→ 91,991 total

Footnotes (1)

[F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Viking Therapeutics, Inc.

CIK 0001607678

Entity typeother

Related Parties

1

filerCIK 0001517780

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 7:13 PM ET
Size: 4.8 KB

View on SEC.gov